Malignant Peritoneal Neoplasm Withdrawn Phase 2 Trials for Olaparib (DB09074)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01661868Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerTreatment